The DOI matches its Crossref record; 64 of the 67 references it cites were found in a registry or an index; 38 of the 56 sources its claims cite were checked for support.
Associations of genetically determined iron status across the phenome: A mendelian randomization study
Open accessAbstract
BACKGROUND: Iron is integral to many physiological processes, and variations in its levels, even within the normal range, can have implications for health. The objective of this study was to explore the broad clinical effects of varying iron status. METHODS AND FINDINGS: Genome-wide association study (GWAS) summary data obtained from 48,972 European individuals (55% female) across 19 cohorts in the Genetics of Iron Status Consortium were used to identify 3 genetic variants (rs1800562 and rs1799945 in the hemochromatosis gene [HFE] and rs855791 in the transmembrane protease serine 6 gene [TMPRSS6]) that associate with increased serum iron, ferritin, and transferrin saturation and decreased transferrin levels, thus serving as instruments for systemic iron status. Phenome-wide association study (PheWAS) of these instruments was performed on 424,439 European individuals (54% female) in the UK Biobank who were aged 40-69 years when recruited from 2006 to 2010, with their genetic data linked to Hospital Episode Statistics (HES) from April, 1995 to March, 2016. Two-sample summary data mendelian randomization (MR) analysis was performed to investigate the effect of varying iron status on outcomes across the human phenome. MR-PheWAS analysis for the 3 iron status genetic instruments was performed separately and then pooled by meta-analysis. Correction was made for testing of multiple correlated phenotypes using a 5% false discovery rate (FDR) threshold. Heterogeneity between MR estimates for different instruments was used to indicate possible bias due to effects of the genetic variants through pathways unrelated to iron status. There were 904 distinct phenotypes included in the MR-PheWAS analyses. After correcting for multiple testing, the 3 genetic instruments for systemic iron status demonstrated consistent evidence of a causal effect of higher iron status on decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a standard deviation [SD] increase in genetically determined serum iron levels 0.72, 95% confidence interval [CI] 0.64-0.81, P = 4 × 10-8) and hypercholesterolemia (hypercholesterolemia: OR 0.88, 95% CI 0.83-0.93, P = 2 × 10-5) and increasing risk of traits related to infection of the skin and related structures (cellulitis and abscess of the leg: OR 1.25, 95% CI 1.10-1.42, P = 6 × 10-4). The main limitations of this study relate to possible bias from pleiotropic effects of the considered genetic variants and misclassification of diagnoses in the HES data. Furthermore, this work only investigated participants with European ancestry, and the findings may not be applicable to other ethnic groups. CONCLUSIONS: Our findings offer novel, to our knowledge, insight into previously unreported effects of iron status, highlighting a potential protective effect of higher iron status on hypercholesterolemia and a detrimental role on risk of skin and skin structure infections. Given the modifiable and variable nature of iron status, these findings warrant further investigation.
Overview
CoChat Summary
TL;DR
In a two-sample mendelian randomization phenome-wide association study, genetically determined higher systemic iron status was associated with lower risk of anemia and hypercholesterolemia but higher risk of skin and soft tissue infections. The authors highlight these as novel, to their knowledge, clinically relevant findings warranting further investigation.
Key findings
- Using 3 iron-status instruments (rs1800562 and rs1799945 in *HFE*, rs855791 in *TMPRSS6*) across 904 phecodes in 424,439 UK Biobank European participants, higher iron status was associated with lower risk of iron deficiency anemia (OR 0.72, 95% CI 0.64–0.81, P = 4 × 10−8) and acute posthemorrhagic anemia (OR 0.35, 95% CI 0.19–0.65, P = 1 × 10−3).
- Higher iron status was associated with lower risk of hypercholesterolemia (OR 0.88, 95% CI 0.83–0.93, P = 2 × 10−5) and cholesterolosis of the gallbladder (OR 0.45, 95% CI 0.28–0.72, P = 9 × 10−4).
- Higher iron status was associated with increased risk of skin and soft tissue infections, including cellulitis and abscess of the leg (OR 1.25, 95% CI 1.10–1.42, P = 6 × 10−4), and with glossitis (OR 2.64, 95% CI 1.56–4.46, P = 3 × 10−4).
- Higher iron status was also associated with lower risk of poisoning by antibiotics (OR 0.74, 95% CI 0.62–0.87, P = 4 × 10−4).
Methods
- Two-sample summary-data mendelian randomization (MR)–PheWAS: instruments were selected from a Genetics of Iron Status Consortium GWAS of 48,972 European individuals (55% female), using 3 SNPs concordantly associated with higher serum iron, ferritin, and transferrin saturation and lower transferrin.
- PheWAS was performed in 424,439 European UK Biobank participants aged 40–69 years recruited in 2006–2010, with genetic data linked to Hospital Episode Statistics from April 1995 to March 2016; 904 distinct phecodes with ≥200 cases were analyzed.
- Logistic regression per SNP adjusted for age, sex, genotyping array, and first 4 principal components; MR estimates used the ratio method scaled to a 1 SD increase in genetically determined serum iron (SD 6.1 μmol/L), pooled by inverse-variance weighted meta-analysis, with 5% false discovery rate correction, Cochran Q heterogeneity testing, weighted median MR sensitivity analysis, and sex-stratified estimates.
Limitations
- The paper states possible bias from pleiotropic effects of the genetic variants, misclassification of diagnoses in HES data, and restriction to European ancestry, so findings may not apply to other ethnic groups.
- The paper also states that UK Biobank lacked serum cholesterol measures, so the magnitude of effect on actual cholesterol levels and lipid fractions could not be quantified; ascertainment bias may affect the antibiotic poisoning finding, and inadequate statistical power may have produced false negatives.
- Evident from the text: only 3 SNPs were used, collectively explaining approximately 3.8% of variation in serum iron; MR estimates relate to small variations within the normal range rather than extremes of iron deficiency or overload, and exclusion of heterogeneous results may have introduced type II error.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
20 Valid · 2 Not valid · 7 Not checked · 41 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“All three of these SNPs have previously been shown to be strong instruments for MR analysis as measured by F-statistics > 10 [8,18]”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Supportedcites [8] D Gill, 2017, The effect of iron status on risk of coronary artery disease: a mendelian randomization study, Arterioscler Thromb Vasc Biol source
The Results state that the three instruments have F statistics ranging from 47 to 2127 across the four iron-status markers. Table 1 lists values above 10 for each SNP, supporting the claim that all three are strong instruments by that threshold. (LLM, conf=0.94)
- Disputedcites [18] TM Palmer, 2012, Using multiple genetic variants as instrumental variables for modifiable risk factors, Stat Methods Med Res sourceExperimental — accuracy not yet measured
Table 3 (§2.4) reports individual first-stage F-statistics above 10 for only two of the four SNPs studied: FTO (39.83) and MC4R (17.85). The text in §2.4 explicitly calls TMEM18 and GNPDA2 weak instruments because their F-statistics are below 10. The source therefore does not show three individual SNPs to be strong by this criterion. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“collectively explain approximately 3.8% of the variation in serum iron [2,8].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Partly supportedcites [2] B Benyamin, 2014, Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis, Nat Commun sourceExperimental — accuracy not yet measured
The Results section ('SNP and gene associations'; page not available) reports that lead SNPs at eleven significant loci explained 3.4% of serum-iron variance in the replication cohorts. It supports the general point that SNPs explain some variation in serum iron, but not the attributed figure of approximately 3.8% for three SNPs. (LLM, conf=0.87)
- Supportedcites [8] D Gill, 2017, The effect of iron status on risk of coronary artery disease: a mendelian randomization study, Arterioscler Thromb Vasc Biol source
Table 1 (reproduced in the Discussion; page not provided) lists serum-iron R² values of 1.3%, 0.9%, and 1.6% for the three SNPs. The table defines R² as the percentage of variation explained by each SNP; the values sum to 3.8%. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The two SNPs in the HFE gene were in low linkage disequilibrium (LD r2 < 0.01) when considering combined European populations with the LDlink resource [2,17].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Could not verifycites [2] B Benyamin, 2014, Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis, Nat Commun sourceExperimental — accuracy not yet measured
The Methods section on HFE C282Y homozygotes identifies rs1800562, but does not report linkage disequilibrium between two HFE SNPs. Searches for the SNP pair, LDlink, and the claimed r² threshold found no measurement for combined European populations in our copy. (LLM, conf=0.74)
- Supportedcites [17] MJ Machiela, 2015, LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants, Bioinformatics source
The citation identifies the LDlink resource used for the calculation, rather than citing its paper as a report of the two HFE SNPs’ result. The Implementation section describes LDpair as reporting linkage-disequilibrium measures for a pair of SNPs and says LDlink permits combinations of populations, including European populations. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A genome-wide association study (GWAS) performed by the Genetics of Iron Status Consortium on 48,972 European subjects (combined Discovery [N = 23,986] and Replication [N = 24,986] cohorts, 55% female) identified 3 such single-nucleotide polymorphisms (SNPs): rs1800562 and rs1799945 in the hemochromatosis (HFE) gene and rs855791 in the transmembrane protease serine 6 (TMPRSS6) gene [2,8,10].”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Methods > Genetic instruments for systemic iron status
What the sources say
- Supportedcites [2] B Benyamin, 2014, Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis, Nat Commun source
Methods > Subjects reports 23,986 European-ancestry discovery subjects and up to 24,986 replication subjects, totaling up to 48,972. Results > Effects at Significant Loci on Gene Expression and Regulation names rs1800562, rs1799945, and rs855791 as SNPs in HFE and TMPRSS6 from the study’s significant loci. The paper reports eleven significant loci overall; the claim identifies three SNPs, not the study’s entire set of findings. (LLM, conf=0.91)
- Partly supportedcites [8] D Gill, 2017, The effect of iron status on risk of coronary artery disease: a mendelian randomization study, Arterioscler Thromb Vasc Biol sourceExperimental — accuracy not yet measured
The Abstract reports a GWAS meta-analysis of 48,972 individuals and names all three SNPs with their HFE and TMPRSS6 genes; Table 1 also lists the three SNPs. Our copy does not substantiate the sentence’s European ancestry, discovery/replication cohort sizes, or 55% female figure. (LLM, conf=0.87)
- Supportedcites [10] D Gill, 2018, Iron Status and Risk of Stroke, Stroke source
The Methods section (page not provided) says the Genetics of Iron Status Consortium meta-analysis combined 48,972 European subjects. It names rs1800562, rs1799945, and rs855791 as the three loci associated with concordant changes in all four iron-status biomarkers. (LLM, conf=0.93)
plainn = 48,972- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“our study pooled MR estimates obtained using all available genetic instruments for iron status, rather than focusing on those related to hereditary hemochromatosis [42]”
§ Associations of genetically determined iron status across the phenome: A mendelian randomization study > Discussion
What the sources say
- Supportedcites [42] LC Pilling, 2019, Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank, BMJ source
The cited paper’s Methods > Mendelian randomisation section describes MR analyses using HFE genotype groups associated with hereditary haemochromatosis. That supports the contrast for which this paper is cited: its MR analysis focused on those genotypes. The statement about what the citing authors pooled describes their own study, not the cited paper. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
37 more claims · 5 with their cited sources checked
Create a free account to see all 70 claims and to verify the 6 references still open.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“however, it requires that the pleiotropic effects are independent of the variant–exposure associations (referred to as the Instrument Strength Independent of Direct Effect (InSIDE) assumption) 17 .”
From Guidelines for performing Mendelian randomization investigations (2020) · cites this paper as [17]
Experimental — accuracy not yet measured
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Self-citationBowden, J., Davey Smith, G., Haycock, P. C., & Burgess, S. (2016) · Genetic Epidemiology · doi:10.1002/gepi.21965 · Cited by 8,922
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050
Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians
Davies, N. M., Holmes, M. V., & Davey Smith, G. (2018) · BMJ · doi:10.1136/bmj.k601 · Cited by 4,404
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Biological, clinical and population relevance of 95 loci for blood lipids
Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,487
Self-citation
Cited by
Guidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.1 · Cited by 1,834
Self-citationGuidelines for performing Mendelian randomization investigations
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.2 · Cited by 1,273
Self-citationGuidelines for performing Mendelian randomization investigations: update for summer 2023
Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Kutalik, Z., Holmes, M. V., Minelli, C., et al. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.3 · Cited by 721
Self-citationWang, X., Fang, X., Zheng, W., Zhou, J., Song, Z., Xu, M., Min, J., & Wang, F. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab454 · Cited by 135
“No causal relationship has been identified previously between instrumented iron status and diabetes using the MR approach (22, 23).”
BackgroundMethodIron, glucose and fat metabolism and obesity: an intertwined relationship
Hilton, C., Sabaratnam, R., Drakesmith, H., & Karpe, F. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01299-0 · Cited by 140
“Although T2DM was not associated with any of the SNPs, hypercholesterolaemia was, suggesting a causal effect of iron status on lipid metabolism [96].”
Background
Metadata
- Authors
- Gill, D., Benyamin, B., Moore, L. S. P., Monori, G., Zhou, A., Koskeridis, F., Evangelou, E., Laffan, M., Walker, A. P., Tsilidis, K. K., Dehghan, A., Elliott, P., Hyppönen, E., & Tzoulaki, I.
- Affiliations
- Imperial College London (GB)
- The University of Queensland (AU)
- Imperial College Healthcare NHS Trust (GB)
- University of South Australia (AU)
- University of Ioannina (GR)
- University College London (GB)
- Public Health England (GB)
- Corresponding author
- Gill, Dipender
- ORCID
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-06-20
- Volume
- 16
- Issue
- 6
- Pages
- e1002833
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6586257
- OpenAlex
- W2949626096
- Cited by
- 63
- References
- 67
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 9 · 2023: 18 · 2022: 9 · 2021: 10 · 2020: 8 · 2019: 2
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Alzheimer's Society
- National Institute for Health and Care Research
- Imperial College London
- Public Health England (MR/L01341X/1)
- UK Dementia Research Institute
- LEO Pharma
- Medical Research Council (MR/L01341X/1)
- National Health and Medical Research Council (1079583, 1084417)
- NIHR Imperial Biomedical Research Centre
- Health Data Research UK
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- iron status, serum iron, ferritin, transferrin saturation, transferrin, HFE gene, TMPRSS6, iron deficiency anemia, hypercholesterolemia, iron overload
- MeSH terms
- Adult, Aged, Female, Humans, Iron, Male, Middle Aged, Phenotype, Prospective Studies, Cohort Studies, Biomarkers, Genome-Wide Association Study, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations of genetically determined iron status across the phenome: A mendelian randomization study. https://app.cochat.ai/papers/10.1371/journal.pmed.1002833
- The paper
- Gill, D., Benyamin, B., Moore, L. S. P., Monori, G., Zhou, A., Koskeridis, F., Evangelou, E., Laffan, M., Walker, A. P., Tsilidis, K. K., Dehghan, A., Elliott, P., Hyppönen, E., & Tzoulaki, I. (2019). Associations of genetically determined iron status across the phenome: A mendelian randomization study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002833
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.